Zobrazeno 1 - 10
of 11
pro vyhledávání: '"M. Y. V. Homs"'
Autor:
J. L. van Dam, E. M. M. Verkolf, E. N. Dekker, B. A. Bonsing, S. O. Bratlie, L. A. A. Brosens, O. R. Busch, L. M. J. W. van Driel, C. H. J. van Eijck, S. Feshtali, P. Ghorbani, D. J. A. de Groot, J. W. B. de Groot, B. C. M. Haberkorn, I. H. de Hingh, B. van der Holt, T. M. Karsten, M. B. van der Kolk, K. J. Labori, M. S. L. Liem, O. J. L. Loosveld, I. Q. Molenaar, M. B. Polée, H. C. van Santvoort, J. de Vos – Geelen, M. L. Wumkes, G. van Tienhoven, M. Y. V. Homs, M. G. Besselink, J. W. Wilmink, B. Groot Koerkamp, for the Dutch Pancreatic Cancer Group
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Surgical resection followed by adjuvant mFOLFIRINOX (5-fluorouracil with leucovorin, irinotecan, and oxaliplatin) is currently the standard of care for patients with resectable pancreatic cancer. The main concern regarding adjuvan
Externí odkaz:
https://doaj.org/article/9bd0b84a5c244ba18797a99563ce5af4
Autor:
Q. P. Janssen, J. L. van Dam, B. A. Bonsing, H. Bos, K. P. Bosscha, P. P. L. O. Coene, C. H. J. van Eijck, I. H. J. T. de Hingh, T. M. Karsten, M. B. van der Kolk, G. A. Patijn, M. S. L. Liem, H. C. van Santvoort, O. J. L. Loosveld, J. de Vos-Geelen, B. M. Zonderhuis, M. Y. V. Homs, G. van Tienhoven, M. G. Besselink, J. W. Wilmink, B. Groot Koerkamp, for the Dutch Pancreatic Cancer Group
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Neoadjuvant therapy has several potential advantages over upfront surgery in patients with localized pancreatic cancer; more patients receive systemic treatment, fewer patients undergo futile surgery, and R0 resection rates are hi
Externí odkaz:
https://doaj.org/article/c4666a70be2f4516b363089ddb9e6b2b
Autor:
T. M. Mackay, F. J. Smits, A. E. J. Latenstein, A. Bogte, B. A. Bonsing, H. Bos, K. Bosscha, L. A. A. Brosens, L. Hol, O. R. C. Busch, G. J. Creemers, W. L. Curvers, M. den Dulk, S. van Dieren, L. M. J. W. van Driel, S. Festen, E. J. M. van Geenen, L. G. van der Geest, D. J. A. de Groot, J. W. B. de Groot, N. Haj Mohammad, B. C. M. Haberkorn, J. T. Haver, E. van der Harst, G. J. M. Hemmink, I. H. de Hingh, C. Hoge, M. Y. V. Homs, N. C. van Huijgevoort, M. A. J. M. Jacobs, E. D. Kerver, M. S. L. Liem, M. Los, H. Lubbinge, S. A. C. Luelmo, V. E. de Meijer, L. Mekenkamp, I. Q. Molenaar, M. G. H. van Oijen, G. A. Patijn, R. Quispel, L. B. van Rijssen, T. E. H. Römkens, H. C. van Santvoort, J. M. J. Schreinemakers, H. Schut, T. Seerden, M. W. J. Stommel, A. J. ten Tije, N. G. Venneman, R. C. Verdonk, J. Verheij, F. G. I. van Vilsteren, J. de Vos-Geelen, A. Vulink, C. Wientjes, F. Wit, F. J. Wessels, B. Zonderhuis, C. H. van Werkhoven, J. E. van Hooft, C. H. J. van Eijck, J. W. Wilmink, H. W. M. van Laarhoven, M. G. Besselink, for the Dutch Pancreatic Cancer Group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-18 (2020)
Abstract Background Pancreatic cancer has a very poor prognosis. Best practices for the use of chemotherapy, enzyme replacement therapy, and biliary drainage have been identified but their implementation in daily clinical practice is often suboptimal
Externí odkaz:
https://doaj.org/article/778d6790076f4b19a04ca4000032fef5
Autor:
F. E. Buisman, M. Y. V. Homs, D. J. Grünhagen, W. F. Filipe, R. J. Bennink, M. G. H. Besselink, I. H. M. Borel Rinkes, R. C. G. Bruijnen, A. Cercek, M. I. D’Angelica, O. M. van Delden, M. L. Donswijk, L. van Doorn, P. G. Doornebosch, J. Emmering, J. I. Erdmann, N. S. IJzerman, C. Grootscholten, J. Hagendoorn, N. E. Kemeny, T. P. Kingham, E. G. Klompenhouwer, N. F. M. Kok, S. Koolen, K. F. D. Kuhlmann, M. C. Kuiper, M. G. E. Lam, R. H. J. Mathijssen, A. Moelker, E. Oomen-de Hoop, C. J. A. Punt, W. W. te Riele, J. M. L. Roodhart, R. J. Swijnenburg, W. Prevoo, P. J. Tanis, M. Vermaas, M. W. J. Versleijen, F. P. Veuger, M. J. Weterman, C. Verhoef, B. Groot Koerkamp
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Recurrences are reported in 70% of all patients after resection of colorectal liver metastases (CRLM), in which half are confined to the liver. Adjuvant hepatic arterial infusion pump (HAIP) chemotherapy aims to reduce the risk of
Externí odkaz:
https://doaj.org/article/d0f854d1c54447efb3a30f326aef6834
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2013 (2013)
Malignant ovarian germ cell tumor is a rare disease, but with current treatment strategies including surgery and platinum based chemotherapy survival is excellent. After treatment, intensive followup is indicated to encounter tumor relapse at an earl
Externí odkaz:
https://doaj.org/article/66f1d7caeb674d95833ee49a67e96356
Autor:
Mackay, T. M., F. J. Smits, A. E. J. Latenstein, A. Bogte, B. A. Bonsing, H. Bos, K. Bosscha, L. A. A. Brosens, L. Hol, O. R. C. Busch, G. J. Creemers, W. L. Curvers, M. Den Dulk, S. Van Dieren, L. M. J. W. Van Driel, S. Festen, E. J. M. Van Geenen, L. G. Van Der Geest, D. J. A. De Groot, J. W. B. De Groot, N. Haj Mohammad, B. C. M. Haberkorn, J. T. Haver, E. Van Der Harst, G. J. M. Hemmink, I. H. De Hingh, C. Hoge, M. Y. V. Homs, N. C. Van Huijgevoort, M. A. J. M. Jacobs, E. D. Kerver, M. S. L. Liem, M. Los, H. Lubbinge, S. A. C. Luelmo, V. E. De Meijer, L. Mekenkamp, I. Q. Molenaar, M. G. H. Van Oijen, G. A. Patijn, R. Quispel, L. B. Van Rijssen, T. E. H. Römkens, H. C. Van Santvoort, J. M. J. Schreinemakers, H. Schut, T. Seerden, M. W. J. Stommel, A. J. Ten Tije, N. G. Venneman, R. C. Verdonk, J. Verheij, F. G. I. Van Vilsteren, J. De Vos-Geelen, A. Vulink, C. Wientjes, F. Wit, F. J. Wessels, B. Zonderhuis, C. H. Van Werkhoven, J. E. Van Hooft, C. H. J. Van Eijck, J. W. Wilmink, H. W. M. Van Laarhoven, M. G. Besselink
Additional file 1. SPIRIT 2013 Checklist for the PACAP-1 trial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5518016faa0f2ed4ae6287148d68b811
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2013 (2013)
Case Reports in Obstetrics and Gynecology
Case Reports in Obstetrics and Gynecology
Malignant ovarian germ cell tumor is a rare disease, but with current treatment strategies including surgery and platinum based chemotherapy survival is excellent. After treatment, intensive followup is indicated to encounter tumor relapse at an earl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b4bee757e05394b51e90c5b43a2a37
https://doaj.org/article/66f1d7caeb674d95833ee49a67e96356
https://doaj.org/article/66f1d7caeb674d95833ee49a67e96356
Publikováno v:
The Cochrane database of systematic reviews. (4)
More than 50% of patients with esophageal cancer have metastatic disease at presentation. The use of chemotherapy for this patient group is increasing with the intention of local and distant tumor control, improving quality of life and prolongation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::15d3c95a6bf62ff5aa05fc49aa1d5475
https://pubmed.ncbi.nlm.nih.gov/20464727
https://pubmed.ncbi.nlm.nih.gov/20464727
Autor:
M Y V, Homs, E W, Steyerberg, W M H, Eijkenboom, H W, Tilanus, L J A, Stalpers, J F W M, Bartelsman, J J B, van Lanschot, H K, Wijrdeman, C J J, Mulder, J G, Reinders, H, Boot, B M P, Aleman, E J, Kuipers, P D, Siersema
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 149(50)
To compare the results of single-dose internal irradiation (brachytherapy) and self-expanding metal stent placement in the palliation of oesophageal obstruction due to cancer of the oesophagus.Randomised trial.In the period from December 1999-Jun 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a839e419e8d02c5ffe65d4e6c1bc3144
https://pubmed.ncbi.nlm.nih.gov/16385829
https://pubmed.ncbi.nlm.nih.gov/16385829
Autor:
P D, Siersema, E M L, Verschuur, M Y V, Homs, A, van der Gaast, W M H, Eijkenboom, E J, Kuipers
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 149(50)
More than 50% of patients with oesophageal carcinoma will undergo palliative treatment because of distant metastases or local tumour ingrowth into surrounding organs. The majority of these patients have symptoms ofdysphagia. If metastases from oesoph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4fb294c65cb43ddc0078f341f636925b
https://pubmed.ncbi.nlm.nih.gov/16385833
https://pubmed.ncbi.nlm.nih.gov/16385833